首页 > 最新文献

European Journal of Vascular and Endovascular Surgery最新文献

英文 中文
Metabolic Phenotyping in Chronic Venous Disease: A Novel Research Avenue. 慢性静脉疾病的代谢表型:新颖的研究途径。
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-05 DOI: 10.1016/j.ejvs.2024.09.040
Maxim E Shaydakov, Jose A Diaz
{"title":"Metabolic Phenotyping in Chronic Venous Disease: A Novel Research Avenue.","authors":"Maxim E Shaydakov, Jose A Diaz","doi":"10.1016/j.ejvs.2024.09.040","DOIUrl":"10.1016/j.ejvs.2024.09.040","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inferior Mesenteric Artery Aneurysm: A Rare Entity. 肠系膜下动脉瘤:罕见的实体。
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-05 DOI: 10.1016/j.ejvs.2024.10.003
Andreja Dimic, Aleksandar Mitrovic
{"title":"Inferior Mesenteric Artery Aneurysm: A Rare Entity.","authors":"Andreja Dimic, Aleksandar Mitrovic","doi":"10.1016/j.ejvs.2024.10.003","DOIUrl":"10.1016/j.ejvs.2024.10.003","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real Evidence: Real Life or Randomised Control Trials? 真实证据:真实生活还是随机对照试验?
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-05 DOI: 10.1016/j.ejvs.2024.10.001
Nabil Chakfé, Anne Lejay
{"title":"Real Evidence: Real Life or Randomised Control Trials?","authors":"Nabil Chakfé, Anne Lejay","doi":"10.1016/j.ejvs.2024.10.001","DOIUrl":"10.1016/j.ejvs.2024.10.001","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142382528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Enhancing the Reliability of Popliteal Artery Aneurysm Treatment Outcomes: A Critical Review of the PARADE Study. 关于"提高腘动脉瘤治疗结果的可靠性:PARADE 研究批判性回顾"。
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-04 DOI: 10.1016/j.ejvs.2024.09.038
Nicola Troisi, Giulia Bertagna, Raffaella Berchiolli
{"title":"Re: Enhancing the Reliability of Popliteal Artery Aneurysm Treatment Outcomes: A Critical Review of the PARADE Study.","authors":"Nicola Troisi, Giulia Bertagna, Raffaella Berchiolli","doi":"10.1016/j.ejvs.2024.09.038","DOIUrl":"10.1016/j.ejvs.2024.09.038","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spontaneous Inferior Mesenteric Artery Occlusion after Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm and its Impact on Clinical Outcomes. 腹主动脉瘤血管内动脉瘤修补术后自发性肠系膜下动脉闭塞及其对临床疗效的影响
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-10-01 DOI: 10.1016/j.ejvs.2024.09.036
Shinichiro Yoshino, Koichi Morisaki, Takehiko Aoyagi, Go Kinoshita, Kentaro Inoue, Tomoharu Yoshizumi

Objective: The incidence and related factors of spontaneous occlusion of a patent inferior mesenteric artery (IMA) after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) without pre-emptive embolisation remain unclear. This study aimed to elucidate the incidence, clinical implications and predictors of spontaneous IMA occlusion after EVAR.

Methods: This was a single centre, retrospective cohort study. Patients who underwent elective EVAR between 2007 and 2022 were categorised into three groups (group 1, spontaneous IMA occlusion; group 2, patent IMA with no type II endoleak (T2EL) from IMA; group 3, T2EL from IMA). Endpoints were the incidence of spontaneous IMA occlusion, sac enlargement, freedom from re-intervention, and overall survival after EVAR.

Results: Of 372 cases of elective EVAR for AAA, 230 who had patent IMA pre-operatively were analysed, after excluding 127 with pre-occluded IMA and 15 who underwent pre-emptive IMA embolisation. Spontaneous IMA occlusion occurred in 101 patients (43.9%). Sac enlargement rate was lower in group 1 than in groups 2 and 3. Freedom from re-intervention rate was higher in group 1 than in group 3 but did not differ between groups 1 and 2. Multivariate analysis revealed the absence of antiplatelet therapy, pre-operative higher haematocrit, absence of concomitant iliac artery aneurysm, posterior thrombus in the sac, and use of Endurant as predictors associated with spontaneous IMA occlusion. Spontaneous IMA occlusion was observed in 7.1% and 77.5% of patients with zero and four or five predictors, respectively.

Conclusion: Spontaneous IMA occlusion occurred in nearly half of cases and was associated with positive clinical outcomes. In patients with a high prediction of spontaneous IMA occlusion, pre-emptive IMA embolisation may be omitted.

目的:腹主动脉瘤(AAA)血管内动脉瘤修补术(EVAR)后,在没有预先栓塞的情况下,肠系膜下动脉(IMA)自发闭塞的发生率和相关因素仍不清楚。本研究旨在阐明EVAR术后IMA自发性闭塞的发生率、临床影响和预测因素:这是一项单中心、回顾性队列研究。2007年至2022年间接受择期EVAR的患者分为三组(第1组,自发性IMA闭塞;第2组,IMA通畅且IMA无II型内漏(T2EL);第3组,IMA有T2EL)。终点是自发性IMA闭塞的发生率、囊肿增大、免于再次介入以及EVAR后的总存活率:在372例AAA择期EVAR病例中,有230例术前IMA通畅,在排除127例术前IMA闭塞和15例术前IMA栓塞后,对这些病例进行了分析。101例患者(43.9%)发生了自发性IMA闭塞。第一组的囊肿扩大率低于第二组和第三组。第 1 组的免于再次介入率高于第 3 组,但第 1 组和第 2 组之间没有差异。多变量分析显示,未接受抗血小板治疗、术前血细胞比容较高、未合并髂动脉瘤、囊后血栓和使用 Endurant 是与自发性 IMA 闭塞相关的预测因素。在预测因素为零、预测因素为四或五的患者中,分别有 7.1% 和 77.5% 出现自发性 IMA 闭塞:结论:自发性 IMA 闭塞发生在近一半的病例中,并与积极的临床结果相关。对于自发性 IMA 闭塞预测较高的患者,可以省略先发制人的 IMA 栓塞治疗。
{"title":"Spontaneous Inferior Mesenteric Artery Occlusion after Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm and its Impact on Clinical Outcomes.","authors":"Shinichiro Yoshino, Koichi Morisaki, Takehiko Aoyagi, Go Kinoshita, Kentaro Inoue, Tomoharu Yoshizumi","doi":"10.1016/j.ejvs.2024.09.036","DOIUrl":"https://doi.org/10.1016/j.ejvs.2024.09.036","url":null,"abstract":"<p><strong>Objective: </strong>The incidence and related factors of spontaneous occlusion of a patent inferior mesenteric artery (IMA) after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) without pre-emptive embolisation remain unclear. This study aimed to elucidate the incidence, clinical implications and predictors of spontaneous IMA occlusion after EVAR.</p><p><strong>Methods: </strong>This was a single centre, retrospective cohort study. Patients who underwent elective EVAR between 2007 and 2022 were categorised into three groups (group 1, spontaneous IMA occlusion; group 2, patent IMA with no type II endoleak (T2EL) from IMA; group 3, T2EL from IMA). Endpoints were the incidence of spontaneous IMA occlusion, sac enlargement, freedom from re-intervention, and overall survival after EVAR.</p><p><strong>Results: </strong>Of 372 cases of elective EVAR for AAA, 230 who had patent IMA pre-operatively were analysed, after excluding 127 with pre-occluded IMA and 15 who underwent pre-emptive IMA embolisation. Spontaneous IMA occlusion occurred in 101 patients (43.9%). Sac enlargement rate was lower in group 1 than in groups 2 and 3. Freedom from re-intervention rate was higher in group 1 than in group 3 but did not differ between groups 1 and 2. Multivariate analysis revealed the absence of antiplatelet therapy, pre-operative higher haematocrit, absence of concomitant iliac artery aneurysm, posterior thrombus in the sac, and use of Endurant as predictors associated with spontaneous IMA occlusion. Spontaneous IMA occlusion was observed in 7.1% and 77.5% of patients with zero and four or five predictors, respectively.</p><p><strong>Conclusion: </strong>Spontaneous IMA occlusion occurred in nearly half of cases and was associated with positive clinical outcomes. In patients with a high prediction of spontaneous IMA occlusion, pre-emptive IMA embolisation may be omitted.</p>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular Aneurysm Repair Surveillance Program Driven by Artificial Intelligence: Is This the Holy Grail of Surveillance? 人工智能驱动的血管内动脉瘤修补监控计划:这是监控的圣杯吗?
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-09-27 DOI: 10.1016/j.ejvs.2024.09.037
Ruth Scicluna, Matthew Joe Grima
{"title":"Endovascular Aneurysm Repair Surveillance Program Driven by Artificial Intelligence: Is This the Holy Grail of Surveillance?","authors":"Ruth Scicluna, Matthew Joe Grima","doi":"10.1016/j.ejvs.2024.09.037","DOIUrl":"10.1016/j.ejvs.2024.09.037","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tourniquet Use in Major Lower Limb Amputation: Useful or Harmful? 在下肢大截肢手术中使用止血带:有用还是有害?
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-09-26 DOI: 10.1016/j.ejvs.2024.09.035
Alexander Gombert
{"title":"Tourniquet Use in Major Lower Limb Amputation: Useful or Harmful?","authors":"Alexander Gombert","doi":"10.1016/j.ejvs.2024.09.035","DOIUrl":"10.1016/j.ejvs.2024.09.035","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Leg Ischaemia: Still a Dilemma. 急性腿部缺血:仍是一个难题。
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-09-26 DOI: 10.1016/j.ejvs.2024.09.034
Jonothan J Earnshaw
{"title":"Acute Leg Ischaemia: Still a Dilemma.","authors":"Jonothan J Earnshaw","doi":"10.1016/j.ejvs.2024.09.034","DOIUrl":"10.1016/j.ejvs.2024.09.034","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impaired Pre-operative Ambulatory Capacity in Patients Undergoing Elective Endovascular Infrarenal Abdominal Aortic Aneurysm Repair is Associated with Increased Peri-operative Death. 接受择期血管内肾下腹主动脉瘤修补术的患者术前活动能力受损与围手术期死亡增加有关。
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-09-26 DOI: 10.1016/j.ejvs.2024.09.031
Heepeel Chang, Frank J Veith, Jae S Cho, Aiden Lui, Igor A Laskowski, Romeo B Mateo, Daniel J Ventarola, Sateesh Babu, Thomas S Maldonado, Karan Garg

Objective: While ambulatory capacity is a readily assessable clinical indicator of functional status, its association with outcomes after endovascular aneurysm repair (EVAR) remains underexplored. This study aimed to investigate the association between pre-operative ambulatory status and outcomes following elective EVAR.

Methods: A retrospective review of the multi-institutional Vascular Quality Initiative database was conducted for all patients who underwent elective infrarenal EVAR from 2009 - 2022. Patients were categorised into independent ambulation and impaired ambulation groups. A propensity score matched analysis was performed to produce two well matched cohorts in a 1:1 ratio without replacement. The primary outcome was 30 day death. Secondary outcomes included one year survival and in hospital major complications.

Results: Among 11 474 patients, 10 539 (91.8%) were independently ambulatory pre-operatively. Propensity score matching resulted in 885 matched pairs. The impaired ambulation group, although older (mean 77.6 vs. 76.3 years; p = .001), showed comparable baseline characteristics. Post-operatively, the impaired ambulation group had higher cumulative in hospital complications and death as well as 30 day death. Even after adjustment for age, impaired pre-operative ambulation was associated with increased in hospital and 30 day death (hazard ratio [HR] 2.27, 95% confidence interval [CI] 1.26 - 3.95; p = .006). Multivariable analysis demonstrated increasing cumulative risk of 30 day death in the setting of impaired pre-operative ambulatory status with age > 75 years requiring post-operative red blood cell transfusion > 2 units (HR 5.75, 95% CI 2.09 - 15.88; p < .001). Beyond 30 days, impaired pre-operative ambulation was not associated with increased one year death (HR 1.09, 95% CI 0.81 - 1.48; p = .570).

Conclusion: Among patients who underwent elective infrarenal EVAR in this matched analysis, impaired pre-operative ambulatory capacity was associated with an increased risk of in hospital and 30 day death, further compounded by advanced age and post-operative transfusion. As such, a threshold higher than the traditional size criteria should be considered in shared decision making when determining options for the management of abdominal aortic aneurysm in this high risk cohort.

目的:虽然活动能力是一项易于评估功能状态的临床指标,但其与血管内动脉瘤修补术(EVAR)后预后的关系仍未得到充分探讨。本研究旨在探讨术前活动能力与择期 EVAR 术后效果之间的关系:方法:对2009年至2022年期间接受择期肾下EVAR的所有患者的多机构血管质量倡议数据库进行了回顾性审查。患者被分为独立行走组和行走不便组。通过倾向得分匹配分析,以1:1的比例产生了两个匹配度较高的组群,且没有替换。主要结果是 30 天死亡。次要结果包括一年生存率和住院主要并发症:在 11 474 名患者中,10 539 人(91.8%)术前可以独立行走。倾向评分匹配得出 885 对匹配结果。尽管行动不便组的年龄更大(平均 77.6 岁对 76.3 岁;P = .001),但其基线特征相当。术后,行动不便组的住院并发症和死亡累积率以及 30 天死亡累积率均较高。即使对年龄进行了调整,术前行走能力受损仍与住院和30天死亡的增加有关(危险比[HR] 2.27,95% 置信区间[CI] 1.26 - 3.95;P = .006)。多变量分析表明,在术前活动能力受损、年龄大于 75 岁、术后需要输注红细胞大于 2 个单位的情况下,30 天内死亡的累积风险会增加(HR 5.75,95% CI 2.09 - 15.88;p < .001)。30天后,术前活动能力受损与一年后死亡的增加无关(HR 1.09,95% CI 0.81 - 1.48;P = .057):结论:在这项匹配分析中,接受择期肾下EVAR手术的患者中,术前活动能力受损与住院和30天内死亡风险增加有关,高龄和术后输血进一步加剧了这一风险。因此,在确定高风险人群腹主动脉瘤治疗方案时,应考虑高于传统尺寸标准的阈值。
{"title":"Impaired Pre-operative Ambulatory Capacity in Patients Undergoing Elective Endovascular Infrarenal Abdominal Aortic Aneurysm Repair is Associated with Increased Peri-operative Death.","authors":"Heepeel Chang, Frank J Veith, Jae S Cho, Aiden Lui, Igor A Laskowski, Romeo B Mateo, Daniel J Ventarola, Sateesh Babu, Thomas S Maldonado, Karan Garg","doi":"10.1016/j.ejvs.2024.09.031","DOIUrl":"10.1016/j.ejvs.2024.09.031","url":null,"abstract":"<p><strong>Objective: </strong>While ambulatory capacity is a readily assessable clinical indicator of functional status, its association with outcomes after endovascular aneurysm repair (EVAR) remains underexplored. This study aimed to investigate the association between pre-operative ambulatory status and outcomes following elective EVAR.</p><p><strong>Methods: </strong>A retrospective review of the multi-institutional Vascular Quality Initiative database was conducted for all patients who underwent elective infrarenal EVAR from 2009 - 2022. Patients were categorised into independent ambulation and impaired ambulation groups. A propensity score matched analysis was performed to produce two well matched cohorts in a 1:1 ratio without replacement. The primary outcome was 30 day death. Secondary outcomes included one year survival and in hospital major complications.</p><p><strong>Results: </strong>Among 11 474 patients, 10 539 (91.8%) were independently ambulatory pre-operatively. Propensity score matching resulted in 885 matched pairs. The impaired ambulation group, although older (mean 77.6 vs. 76.3 years; p = .001), showed comparable baseline characteristics. Post-operatively, the impaired ambulation group had higher cumulative in hospital complications and death as well as 30 day death. Even after adjustment for age, impaired pre-operative ambulation was associated with increased in hospital and 30 day death (hazard ratio [HR] 2.27, 95% confidence interval [CI] 1.26 - 3.95; p = .006). Multivariable analysis demonstrated increasing cumulative risk of 30 day death in the setting of impaired pre-operative ambulatory status with age > 75 years requiring post-operative red blood cell transfusion > 2 units (HR 5.75, 95% CI 2.09 - 15.88; p < .001). Beyond 30 days, impaired pre-operative ambulation was not associated with increased one year death (HR 1.09, 95% CI 0.81 - 1.48; p = .570).</p><p><strong>Conclusion: </strong>Among patients who underwent elective infrarenal EVAR in this matched analysis, impaired pre-operative ambulatory capacity was associated with an increased risk of in hospital and 30 day death, further compounded by advanced age and post-operative transfusion. As such, a threshold higher than the traditional size criteria should be considered in shared decision making when determining options for the management of abdominal aortic aneurysm in this high risk cohort.</p>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short Term Outcomes of a Prospective Registry in Popliteal and Infrapopliteal Endovascular Interventions for Chronic Limb Threatening Ischaemia. 腘窝和腘下血管内介入治疗慢性肢体缺血的前瞻性登记的短期效果。
IF 5.7 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2024-09-26 DOI: 10.1016/j.ejvs.2024.09.033
Michael J Nugteren, Constantijn E V B Hazenberg, Olaf J Bakker, Maarten K Dinkelman, Bram Fioole, Jan-Willem Hinnen, Maurice Pierie, Gert J de Borst, Çağdaş Ünlü

Objective: The prevalence of chronic limb threatening ischaemia (CLTI) is increasing worldwide, resulting in the need for more patients undergoing revascularisation, especially for below the knee pathology. Nevertheless, prospective data on below the knee endovascular interventions are lacking. The aim of the study was to provide large scale, real world data on procedural and short term outcomes of popliteal and infrapopliteal endovascular interventions in patients with CLTI.

Methods: This study is an analysis of the first 1 000 interventions of the Dutch Chronic Lower Limb-Threatening Ischemia Registry (THRILLER). It includes all patients with CLTI undergoing popliteal or infrapopliteal endovascular revascularisation in seven hospitals in the Netherlands. The primary outcomes were limb salvage and amputation free survival (AFS) at three months estimated with the Kaplan-Meier method. Secondary outcomes were procedural complications and primary patency.

Results: Between February 2021 and July 2023, 1 000 endovascular procedures were performed in 840 patients (947 limbs), treating 486 popliteal and 1 209 tibial lesions. Wound, Ischemia, and foot Infection (WIfI) stages 1 - 4 were present in 16.8%, 17.2%, 25.4%, and 40.6% of the limbs, respectively. Technical success was hampered by arterial perforation, acute thrombosis, and distal embolisation in 8.7%, 1.0%, and 2.3% of the interventions, respectively. Limb salvage was 100.0%, 96.9%, 94.9%, and 86.1% (p < .001), whereas AFS was 96.9%, 93.2%, 86.6%, and 76.4% for WIfI stages 1 - 4 at three months (p < .001), respectively. Primary patency at the 6 - 8 week visit was 86.4% for popliteal and 74.3% for tibial lesions, respectively.

Conclusion: THRILLER presents a large prospective database on outcomes of CLTI endovascular interventions. Popliteal and infrapopliteal endovascular revascularisation for CLTI is safe. Interventions with initial technical success have high rates of limb salvage and survival at three months. The WIfI classification provides a reliable instrument to predict limb salvage and AFS independently at three months.

目的:慢性肢体缺血(CLTI)的发病率在全球范围内不断上升,因此需要对更多患者进行血管重建,尤其是膝下病变患者。然而,目前还缺乏膝下血管内介入治疗的前瞻性数据。该研究旨在提供大规模的真实数据,说明腘动脉和膝下动脉血管内介入治疗CLTI患者的程序和短期疗效:本研究是对荷兰慢性下肢危重缺血登记处(THRILLER)前 1000 例介入治疗的分析。研究对象包括在荷兰七家医院接受腘部或腘下血管内再通术的所有慢性下肢危重缺血患者。主要结果是三个月后的肢体挽救率和无截肢存活率(AFS),采用 Kaplan-Meier 法进行估算。次要结果为手术并发症和主要通畅率:结果:2021 年 2 月至 2023 年 7 月期间,为 840 名患者(947 条肢体)实施了 1000 例血管内手术,治疗了 486 例腘动脉病变和 1 209 例胫骨病变。分别有16.8%、17.2%、25.4%和40.6%的肢体出现伤口、缺血和足部感染(WIfI)1-4期。分别有8.7%、1.0%和2.3%的介入手术因动脉穿孔、急性血栓形成和远端栓塞而影响了技术成功率。三个月后,肢体挽救率分别为 100.0%、96.9%、94.9% 和 86.1%(P < .001),而 WIfI 1 - 4 期的 AFS 分别为 96.9%、93.2%、86.6% 和 76.4%(P < .001)。腘窝和胫骨病变在6-8周就诊时的初次通畅率分别为86.4%和74.3%:THRILLER提供了一个大型前瞻性数据库,用于研究CLTI血管内介入治疗的效果。腘窝和胫骨下血管内血运重建治疗CLTI是安全的。最初技术成功的介入治疗具有较高的肢体挽救率和三个月的存活率。WIfI分类法是独立预测三个月后肢体挽救率和AFS的可靠工具。
{"title":"Short Term Outcomes of a Prospective Registry in Popliteal and Infrapopliteal Endovascular Interventions for Chronic Limb Threatening Ischaemia.","authors":"Michael J Nugteren, Constantijn E V B Hazenberg, Olaf J Bakker, Maarten K Dinkelman, Bram Fioole, Jan-Willem Hinnen, Maurice Pierie, Gert J de Borst, Çağdaş Ünlü","doi":"10.1016/j.ejvs.2024.09.033","DOIUrl":"https://doi.org/10.1016/j.ejvs.2024.09.033","url":null,"abstract":"<p><strong>Objective: </strong>The prevalence of chronic limb threatening ischaemia (CLTI) is increasing worldwide, resulting in the need for more patients undergoing revascularisation, especially for below the knee pathology. Nevertheless, prospective data on below the knee endovascular interventions are lacking. The aim of the study was to provide large scale, real world data on procedural and short term outcomes of popliteal and infrapopliteal endovascular interventions in patients with CLTI.</p><p><strong>Methods: </strong>This study is an analysis of the first 1 000 interventions of the Dutch Chronic Lower Limb-Threatening Ischemia Registry (THRILLER). It includes all patients with CLTI undergoing popliteal or infrapopliteal endovascular revascularisation in seven hospitals in the Netherlands. The primary outcomes were limb salvage and amputation free survival (AFS) at three months estimated with the Kaplan-Meier method. Secondary outcomes were procedural complications and primary patency.</p><p><strong>Results: </strong>Between February 2021 and July 2023, 1 000 endovascular procedures were performed in 840 patients (947 limbs), treating 486 popliteal and 1 209 tibial lesions. Wound, Ischemia, and foot Infection (WIfI) stages 1 - 4 were present in 16.8%, 17.2%, 25.4%, and 40.6% of the limbs, respectively. Technical success was hampered by arterial perforation, acute thrombosis, and distal embolisation in 8.7%, 1.0%, and 2.3% of the interventions, respectively. Limb salvage was 100.0%, 96.9%, 94.9%, and 86.1% (p < .001), whereas AFS was 96.9%, 93.2%, 86.6%, and 76.4% for WIfI stages 1 - 4 at three months (p < .001), respectively. Primary patency at the 6 - 8 week visit was 86.4% for popliteal and 74.3% for tibial lesions, respectively.</p><p><strong>Conclusion: </strong>THRILLER presents a large prospective database on outcomes of CLTI endovascular interventions. Popliteal and infrapopliteal endovascular revascularisation for CLTI is safe. Interventions with initial technical success have high rates of limb salvage and survival at three months. The WIfI classification provides a reliable instrument to predict limb salvage and AFS independently at three months.</p>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":null,"pages":null},"PeriodicalIF":5.7,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Vascular and Endovascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1